source
- Madrigal ex-clinical head sues, alleging liver-injury data cover-up for RezdiffraMadrigal Pharmaceuticals is being sued by its former senior vice president and head of clinical development, Michael Charlton, who claims senior leaders suppressed serious liver‑injury data for the…
- Minghui licenses sub-q TED drug to Japan's ASKA in up to $440 million dealMinghui Pharmaceutical of China has signed a licensing agreement with Japan's ASKA Pharmaceutical, granting exclusive rights to develop and sell its late‑stage thyroid eye disease (TED) candidate i…